Octagon Capital Advisors LP: holdings and changes
Number 93 of the top 100 funds by copy return. Octagon Capital Advisors LP reported 25 US stocks worth $739M for the quarter ending 2026-09-30 and changed 2 new, 1 added, 13 trimmed and 3 sold since 2026-06-30.
Copy return, 4 quarters+34.4%
US 500, same time+14.5%
Size$739M
Stocks25
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| DNTH Dianthus Therapeutics INC | TRIM -8% | 20.08% | $148M | 1,686,667 |
| ABVX Abivax Sa-Adr | 13.30% | $98M | 993,000 | |
| DFTX Definium Therapeutics INC | TRIM -15% | 12.92% | $96M | 2,511,000 |
| COGT Cogent Biosciences INC | 10.18% | $75M | 2,350,000 | |
| AVBP Arrivent Biopharma INC | ADD +9% | 8.77% | $65M | 2,141,387 |
| TSHA Taysha Gene Therapies INC Com Shs | 6.38% | $47M | 9,693,244 | |
| OBX Obsidian Therapeutics INC | BUY | 4.48% | $33M | 2,414,610 |
| KYMR Kymera Therapeutics INC | TRIM -34% | 3.10% | $23M | 205,000 |
| IRON Disc Medicine INC | 2.39% | $18M | 270,000 | |
| TNGX Tango Therapeutics INC | BUY | 2.13% | $16M | 630,000 |
| XENE Xenon Pharmaceuticals INC | TRIM -14% | 2.11% | $16M | 420,000 |
| ANL Adlai Nortye LTD | 2.02% | $15M | 934,716 | |
| MIRM Mirum Pharmaceuticals, INC. | TRIM -50% | 1.96% | $14M | 169,450 |
| AKTS Aktis Oncology INC | TRIM -26% | 1.88% | $14M | 713,000 |
| PALI Palisade Bio INC | 1.88% | $14M | 10,276,317 | |
| BIOA Bioage Labs INC | TRIM -26% | 1.25% | $9M | 1,300,000 |
| PHVS Pharvaris N V | TRIM -45% | 1.07% | $8M | 249,000 |
| GYRE Gyre Therapeutics INC | 0.95% | $7M | 954,416 | |
| DBVT Dbv Technologies S A | 0.91% | $7M | 574,200 | |
| OCUL Ocular Therapeutix INC | TRIM -71% | 0.62% | $5M | 599,900 |
| TRVI Trevi Therapeutics | 0.61% | $4M | 315,000 | |
| SENSEI BIOTHER Sensei Biotherapeutics INC | TRIM -72% | 0.40% | $3M | 100,000 |
| DTIL Precision Biosciences INC | TRIM -68% | 0.36% | $3M | 430,000 |
| UNCY Unicycive Therapeutics INC | TRIM -72% | 0.17% | $1M | 275,000 |
| GOSS Gossamer Bio INC | TRIM -54% | 0.08% | $600k | 96,875 |
| ALMS Alumis INC | SELL | 0% | was $80M | 0 |
| SMMT Summit Therapeutics | SELL | 0% | was $18M | 0 |
| CNTX Context Therapeutics INC | SELL | 0% | was $2M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-09-30 → 2023-12-31 | +33.8% | +11.2% |
| 2023-12-31 → 2024-03-31 | +6.6% | +10.0% |
| 2024-03-31 → 2024-06-30 | -8.9% | +4.0% |
| 2024-06-30 → 2024-09-30 | +3.9% | +5.4% |
| 2024-09-30 → 2024-12-31 | -6.1% | +2.1% |
| 2024-12-31 → 2025-03-31 | -18.8% | -4.6% |
| 2025-03-31 → 2025-06-30 | +9.6% | +10.5% |
| 2025-06-30 → 2025-09-30 | +46.5% | +7.8% |
| 2025-09-30 → 2025-12-31 | +31.9% | +2.4% |
| 2025-12-31 → 2026-03-31 | +17.3% | -4.6% |
| 2026-03-31 → 2026-06-30 | +16.8% | +14.8% |
| 2026-06-30 → 2026-09-30 | -25.7% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP